CLINICAL EVALUATION OF TOLCYCLAMIDE IN TREATMENT OF DIABETES MELLITUS

dc.contributor.authorVILLAR
dc.contributor.authorPAULLADA
dc.date.accessioned2026-05-28T16:37:51Z
dc.date.issued1974
dc.description.paginacion221 -
dc.description.procedenciaEXT
dc.format.discursoArtículo
dc.format.extent1
dc.identifier.issn0026-0495
dc.identifier.urihttps://ahcm.cinvestav.mx/handle/ahcm/25182
dc.language.isoInglés
dc.numero.secuencia25179
dc.publisherGroup on Research in Cancer and Hormones, Hospital General, Pab. 13, Mexico City, D.F.
dc.publisherSyntex Laboratories, S. W., Mexico City, D.F.
dc.relation.ispartofseriesVol. 10 No. 3
dc.source.revistafuenteMETABOLISM CLINICAL AND EXPERIMENTAL
dc.subjectCLINICAL, EVALUATION, TOLCYCLAMIDE, TREATMENT, DIABETES, MELLITUS
dc.subject.categoriaprincipalCIENCIAS MEDICAS
dc.subject.disciplinaPATOLOGIA
dc.subject.subdisciplinaPATOLOGIA CLINICA
dc.titleCLINICAL EVALUATION OF TOLCYCLAMIDE IN TREATMENT OF DIABETES MELLITUS
dc.title.alternativeMETAB CLIN EXP

Files